Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 9, 2023
Enhancing oral delivery of plant-derived vesicles for colitis
Yuan Liu, Adrian Lankenau Ahumada, Emine Bayraktar, et al.
The British Journal of Dermatology
|
February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy
C A Morton, R Dominicus, P Radny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2018
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
A Kron, C Alidousty, M Scheffler, et al.
The British Journal of Dermatology
|
September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
T Dirschka, P Radny, R Dominicus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2026
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
N Frost, M Joosten, J Franzen, et al.
The British Journal of Dermatology
|
December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
T Dirschka, P Radny, R Dominicus, et al.
ESMO Open
|
February 13, 2024
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial
S Michels, B Massutí, I Vasyliv, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
M Janning, J Süptitz, C Albers-Leischner, et al.
NPJ Breast Cancer
|
May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 9, 2023
Enhancing oral delivery of plant-derived vesicles for colitis
Yuan Liu, Adrian Lankenau Ahumada, Emine Bayraktar, et al.
The British Journal of Dermatology
|
February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy
C A Morton, R Dominicus, P Radny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2018
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
A Kron, C Alidousty, M Scheffler, et al.
The British Journal of Dermatology
|
September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
T Dirschka, P Radny, R Dominicus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2026
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
N Frost, M Joosten, J Franzen, et al.
The British Journal of Dermatology
|
December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
T Dirschka, P Radny, R Dominicus, et al.
ESMO Open
|
February 13, 2024
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial
S Michels, B Massutí, I Vasyliv, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
M Janning, J Süptitz, C Albers-Leischner, et al.
NPJ Breast Cancer
|
May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
Page
of 15